Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

A smartphone-based diagnostic platform for rapid detection of Zika, chikungunya, and dengue viruses

Aashish PriyeDepartment of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, 94550, USASara W. BirdDepartment of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, 94550, USAYooli Kim LightDepartment of Systems Biology, Sandia National Laboratories, Livermore, CA, 94550, USACameron Scott BallDepartment of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, 94550, USAOscar NegreteDepartment of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, 94550, USARobert J. MeagherDepartment of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, 94550, USA
2017en
ABI

Аннотация

Current multiplexed diagnostics for Zika, dengue, and chikungunya viruses are situated outside the intersection of affordability, high performance, and suitability for use at the point-of-care in resource-limited settings. Consequently, insufficient diagnostic capabilities are a key limitation facing current Zika outbreak management strategies. Here we demonstrate highly sensitive and specific detection of Zika, chikungunya, and dengue viruses by coupling reverse-transcription loop-mediated isothermal amplification (RT-LAMP) with our recently developed quenching of unincorporated amplification signal reporters (QUASR) technique. We conduct reactions in a simple, inexpensive and portable "LAMP box" supplemented with a consumer class smartphone. The entire assembly can be powered by a 5 V USB source such as a USB power bank or solar panel. Our smartphone employs a novel algorithm utilizing chromaticity to analyze fluorescence signals, which improves the discrimination of positive/negative signals by 5-fold when compared to detection with traditional RGB intensity sensors or the naked eye. The ability to detect ZIKV directly from crude human sample matrices (blood, urine, and saliva) demonstrates our device's utility for widespread clinical deployment. Together, these advances enable our system to host the key components necessary to expand the use of nucleic acid amplification-based detection assays towards point-of-care settings where they are needed most.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0